Behavioral Activation for treating Bipolar Depression
Official title: Adjunctive Behavioural Activation for Bipolar Depression: A Case Series (BA-BD)
Run by Reykjavik University · NCT06022913 · Data updated 2026-11-12
This study is testing a new therapy called Behavioral Activation to see if it can help people with Bipolar Disorder who are feeling depressed by encouraging healthier activities and better sleep.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 10 (estimated) |
| Sponsor | Reykjavik University Academic / other |
| Locations | 1 site (Reykjavik) |
| Status | Recruiting |
| Started | November 22, 2023 |
| Main results expected | December 31, 2025 |
| Study ends | December 31, 2025 |
| Registry record updated | April 16, 2025 |
| Trial ID | NCT06022913 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are individuals diagnosed with Bipolar I or II Disorder who are currently experiencing depressive episodes.
✕Probably not a fit
Patients with current or past learning disabilities, severe substance dependence, or those at marked risk of self-harm may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to implement Behavioral Activation (BA) therapy for individuals experiencing depression associated with Bipolar Disorder (BD). BA is a therapeutic approach that focuses on helping patients re-establish healthier activity patterns and improve sleep regulation, which is crucial for mood stabilization in BD. The research will assess the feasibility of BA for this specific patient group, as there is limited existing research on its effectiveness for bipolar depression. Participants will be evaluated based on their depression severity and must meet specific diagnostic criteria for Bipolar I or II Disorder.
Why it matters
Potential benefit: If successful, this approach could provide an effective therapeutic option for managing depression in patients with Bipolar Disorder.
How similar studies have gone: While BA has been proven effective for unipolar depression, its application in bipolar depression is less explored, making this a novel approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * scoring in the clinical range on a self-report measure of depression severity (the PHQ-9) meeting diagnostic criteria for depression based on a diagnosis on Diagnostic Interview for Anxiety, Mood, and OCD and Related Neuropsychiatric Disorders (DIAMOND) meeting diagnostic criteria for Bipolar I or II Disorder DIAMOND) participants will require a working knowledge of written and spoken Icelandic, sufficient to make use of therapy and complete research assessments without the need for a translator. Exclusion Criteria: * current/past learning disability, organic brain change, substance dependence (drugs and alcohol) that would compromise the ability to use therapy * current marked risk to self (i.e., self-harm or suicide) that we deem could not be appropriately managed in the Bipolar outpatient clinic at Landspitali. * currently lacking the capacity to give informed consent * currently receiving other psychosocial therapy for depression or bipolar disorder * presence of another area of difficulty that the therapist and client believe should be the primary focus of intervention (for example, Post-Traumatic Stress Disorder, psychosis)
Where it's running
-
Landspitali university hospital
Reykjavik, Iceland Recruiting
Study contacts
- Principal investigator: Anna S Islind, PhD — Reykjavik University
- Study coordinator: Halla Ó Ólafsdóttir, Cand. psych
- Email: hallaosh@landspitali.is
- Phone: 8688371
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
SCC Deep Brain Stimulation for Bipolar Depression in Bipolar I Patients
A small study tests whether deep brain stimulation of the subcallosal cingulate can help people with bipolar I depression who have not improved with other treatments, while monitoring brain signals to watch for manic switches.
-
EEG microstates and inflammatory biomarkers in older adults with major depression receiving ECT
This study tests how ECT affects brain wave patterns and inflammatory markers in people 55 and older with major depression.
-
RNA editing to predict antidepressant response in unipolar and bipolar depression
This project tests whether changes in RNA editing can predict how adults with unipolar or bipolar depression respond to antidepressant treatment.
-
High-definition tDCS targeting the primary somatosensory cortex for adolescent bipolar depression
This trial will try high-definition transcranial direct current stimulation (HD-tDCS) to reduce depressive symptoms in adolescents aged 12–18 with bipolar depression, compared with a sham procedure.
-
Ketogenic diet for bipolar depression
This study will try a high-fat, very low-carbohydrate (ketogenic) diet to see if it helps adults aged 18–50 with bipolar depression.
-
MR-guided focused ultrasound bilateral capsulotomy for refractory bipolar depression
This will try MR-guided focused ultrasound capsulotomy to see if it helps adults with treatment-resistant bipolar depression.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.